Species: Aggregatibacter aphrophilus (HMT-0545) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0545: [Body Sites Data]
[Taxon Description]
| Life Page: Aggregatibacter aphrophilus
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.44 | 0.49 | 0.02 | 0.10 | 0.16 | 0.04 | 0.37 | 0.04 | 0.05 | 0.05 | 0.01 | 0.01 | 0.04 | 0.01 | 0 | 0.01 | 0 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.04 | 0.03 | 0 | 0.04 | 0.03 | 0.04 | 0.04 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| 90thp | 1.09 | 1.04 | 0.06 | 0.18 | 0.33 | 0.04 | 0.82 | 0.07 | 0.07 | 0.12 | 0.03 | 0.03 | 0.02 | 0.01 | 0 | 0.03 | 0 | 0 |
| Stdev | 0.48 | 1.04 | 0.05 | 0.07 | 0.15 | 0 | 0.49 | 0.04 | 0.06 | 0.06 | 0.02 | 0.03 | 0.17 | 0 | 0 | 0.02 | 0.01 | 0.04 |
| Prev(%) | 58.33 | 54.68 | 0 | 6.67 | 8.67 | 0 | 25.00 | 0 | 4.55 | 6.38 | 0 | 0 | 6.67 | 0 | 0 | 0 | 0 | 0.27 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.19 | 0.08 | 0 | 0 | 0 | 0.02 | 0.02 | 0.07 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.56 | 0.21 | 0 | 0 | 0 | 0.04 | 0 | 0.01 | 0 | 0 |
| Stdev | 0.55 | 0.25 | 0.01 | 0.01 | 0.01 | 0.07 | 0.17 | 0.51 | 0 | 0 |
| Prev(%) | 27.03 | 21.62 | 2.03 | 7.43 | 6.76 | 18.92 | 5.41 | 12.84 | 2.70 | 0 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Neither HMT-545 nor HMT-720 were present singularly so these reads were split evenly at this site (PTO).
Because HMT-720 is not present individually, all equidistant reads were assigned to HMT-545 at this body site (SUPP).
Neither HMT-545 nor HMT-720 were present singularly so these reads were split evenly at this site (PTO).
Because HMT-720 is not present individually, all equidistant reads were assigned to HMT-545 at this body site (SUPP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.13 | 0.16 | 0.02 | 0.01 | 0 | 0.01 | 0.01 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.24 | 0.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.43 | 0.63 | 0.17 | 0.08 | 0.03 | 0.08 | 0.11 | 0.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 45.03 | 44.37 | 3.50 | 6.85 | 4.70 | 5.38 | 8.33 | 10.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Because HMT-720 is not present individually, all equidistant reads were assigned to HMT-545 at these sites (PTO,SAL,SUBP,SUPP).
Because HMT-720 is not present individually, all equidistant reads were assigned to HMT-545 at these sites (PTO,SAL,SUBP,SUPP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 1.03 | 1.28 | 0.18 | 0.12 | 0.03 | 0.27 | 0 | 0.36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 2.89 | 3.58 | 0.37 | 0.25 | 0.07 | 0.61 | 0 | 0.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 2.20 | 3.22 | 0.77 | 0.41 | 0.14 | 0.78 | 0 | 2.96 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 71.61 | 71.46 | 43.70 | 37.72 | 23.27 | 60.42 | 0 | 41.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.24 | 0.07 | 0.07 | 0.34 | 0.03 | 0.03 | 0.01 | 0.03 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.78 | 0.18 | 0.04 | 0.12 | 0.07 | 0.05 | 0.01 | 0.05 | 0.02 | 0 |
| Stdev | 0.76 | 0.15 | 0.34 | 1.78 | 0.07 | 0.10 | 0.05 | 0.10 | 0.02 | 0 |
| Prev(%) | 59.46 | 64.71 | 44.19 | 74.29 | 64.29 | 58.00 | 39.39 | 45.16 | 42.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.35 | 0.41 | 0 | 0 | 0.03 | 0 | 0.22 | 0.05 | 0.01 | 0 | 0 | 0.01 | 0.04 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.82 | 0.65 | 0 | 0.01 | 0.03 | 0 | 0.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.53 | 1.35 | 0.01 | 0.01 | 0.16 | 0 | 0.25 | 0.20 | 0.03 | 0.01 | 0.01 | 0.04 | 0.18 | 0 | 0 | 0 | 0 | 0.04 |
| Prev(%) | 66.67 | 47.98 | 4.17 | 17.65 | 15.16 | 0 | 75.00 | 6.25 | 8.00 | 3.76 | 0.90 | 8.33 | 6.25 | 0 | 0 | 0 | 0 | 0.18 |

